Absci (ABSI) EBIT Margin Growth (1y) (2021 - 2026)
Absci (ABSI) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Absci |
1.13 Bn |
1.01 Bn |
- |
-1.20 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-1.20 Mn |
| Dec 31, 2025 |
-29,825.00 |
| Sep 30, 2025 |
-627,854.00 |
| Jun 30, 2025 |
-318,991.00 |
| Mar 31, 2025 |
26,480.00 |
| Dec 31, 2024 |
284,194.00 |
| Sep 30, 2024 |
143,342.00 |
| Jun 30, 2024 |
-82,727.00 |
| Mar 31, 2024 |
-68,723.00 |
| Dec 31, 2023 |
997,011.00 |
| Sep 30, 2023 |
-195,158.00 |
| Jun 30, 2023 |
160,619.00 |
| Mar 31, 2023 |
596,176.00 |
| Dec 31, 2022 |
-1.34 Mn |
| Sep 30, 2022 |
34,047.00 |
| Jun 30, 2022 |
939,060.00 |
| Mar 31, 2022 |
117,218.00 |
| Dec 31, 2021 |
-375,187.00 |
| Sep 30, 2021 |
-115,376.00 |
| Jun 30, 2021 |
-1.18 Mn |
